Abstract:Atopic dermatitis (AD) is a common inflammatory skin condition occurring in both pediatric and adult patients. Pruritus is a clinical hallmark of the disease, and patients with AD often experience disruptions to their quality of life. The pathogenesis of AD is a complex and multifactorial interplay between genetic factors, epidermal barrier disruption, and immune dysregulation . Clinically, AD is characterized by pruritus, eczematous skin changes, and age-specific lesion distribution patterns. Infants and young children tend to have AD lesions on their face and extensor surfaces of their extremities while older children and adults tend to have AD lesions on flexural surfaces of their extremities. Many patients also experience a chronic and relapsing disease course. Due to the chronicity and severe pruritus, lesions often undergo secondary changes like lichenification. Patients with AD can experience a number of comorbidities including other atopic disease (i.e. allergic rhinitis, asthma), skin infections, cardiovascular, and neuropsychiatric illnesses. Management of AD depends on the severity of the disease as well as the distribution of the disease. Traditionally, treatment of AD included the use of moisturizers / emollients, topical corticosteroids or topical calcineurin inhibitors, or systemic therapy with non-selective immunosuppressants such as corticosteroids, cyclosporine , azathioprine, or similar. However, in the past decade, new biologic and small molecule drugs, both topical and systemic, have become important therapeutic options for AD patients, especially for those with moderate-to-severe disease. The development of these medications, following decades of research to better understand AD, are designed to specifically target various components of immune dysregulation and inflammation implicated in the pathogenesis of AD. Their successful development and deployment now allow for an exciting new era of treatment for individuals suffering from atopic dermatitis.

Medications for atopic dermatitis

Update on the Pathogenesis and Therapy of Atopic Dermatitis

Therapeutic management of atopic dermatitis

Updates in atopic dermatitis for the primary care physician: A review of advances in the understanding and treatment of atopic dermatitis

Exploring the Complexities of Atopic Dermatitis: Pathophysiological Mechanisms and Therapeutic Approaches

Atopic dermatitis: a brief review of recent advances in management

Cellular and molecular mechanisms in atopic dermatitis

Integrative Medicine as Adjunct Therapy in the Treatment of Atopic Dermatitis—the Role of Traditional Chinese Medicine, Dietary Supplements, and Other Modalities

Molecular Biology of Atopic Dermatitis

Atopic dermatitis: new insight into the etiology, pathogenesis, diagnosis and novel treatment strategies

Biologics and Oral Small-Molecule Inhibitors for Treatment of Pediatric Atopic Dermatitis: Opportunities and Challenges

Atopic dermatitis

The Roles of Innate Immune Cells in Atopic Dermatitis

The Role of Genetics, the Environment, and Epigenetics in Atopic Dermatitis

Current Research on Pathogenesis and Treatment of Atopic Dermatitis

The formulae and biologically active ingredients of Chinese herbal medicines for the treatment of atopic dermatitis

Biologics in the Treatment of Atopic Dermatitis

A comprehensive review of natural products against atopic dermatitis: Flavonoids, alkaloids, terpenes, glycosides and other compounds

Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis

Gut Microbiota, Probiotics, and Their Interactions in Prevention and Treatment of Atopic Dermatitis: A Review

Pharmacological Trends in the Management of Atopic Dermatitis: A Comprehensive Review